195 related articles for article (PubMed ID: 31548812)
1. Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada.
Squires JE; Simard SN; Asad S; Stacey D; Graham ID; Coughlin M; Clemons M; Grimshaw JM; Zhang J; Caudrelier JM; Arnaout A
Curr Oncol; 2019 Aug; 26(4):e439-e457. PubMed ID: 31548812
[TBL] [Abstract][Full Text] [Related]
2. Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?
Schellenberg AE; Stypulkowski A; Cordeiro E; Holloway CMB; Eisen A; Scheer AS
Ann Surg Oncol; 2019 Oct; 26(11):3489-3494. PubMed ID: 31187367
[TBL] [Abstract][Full Text] [Related]
3. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
Tollow P; Williams VS; Harcourt D; Paraskeva N
Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
[TBL] [Abstract][Full Text] [Related]
4. Patient decision aid for contralateral prophylactic mastectomy for use in the consultation: a feasibility study.
Squires JE; Stacey D; Coughlin M; Greenough M; Roberts A; Dorrance K; Clemons M; Caudrelier JM; Graham ID; Zhang J; Varin MD; Arnaout A
Curr Oncol; 2019 Apr; 26(2):137-148. PubMed ID: 31043816
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
6. Reframing the conversation about contralateral prophylactic mastectomy: Preparing women for postsurgical realities.
Bloom DL; Chapman BM; Wheeler SB; McGuire KP; Lee CN; Weinfurt K; Rosenstein DL; Plichta JK; Jacobson Vann JC; Hwang ES
Psychooncology; 2019 Feb; 28(2):394-400. PubMed ID: 30500102
[TBL] [Abstract][Full Text] [Related]
7. Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.
Katz SJ; Janz NK; Abrahamse P; Wallner LP; Hawley ST; An LC; Ward KC; Hamilton AS; Morrow M; Jagsi R
JAMA Surg; 2017 Jul; 152(7):658-664. PubMed ID: 28384687
[TBL] [Abstract][Full Text] [Related]
8. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
Scheepens JCC; Veer LV'; Esserman L; Belkora J; Mukhtar RA
Breast; 2021 Apr; 56():61-69. PubMed ID: 33621798
[TBL] [Abstract][Full Text] [Related]
9. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
10. Indications for Contralateral Prophylactic Mastectomy: A Consensus Statement Using Modified Delphi Methodology.
Wright FC; Look Hong NJ; Quan ML; Beyfuss K; Temple S; Covelli A; Baxter N; Gagliardi AR
Ann Surg; 2018 Feb; 267(2):271-279. PubMed ID: 28594745
[TBL] [Abstract][Full Text] [Related]
11. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
12. Decreasing contralateral prophylactic mastectomy rates in average-risk women with unilateral breast cancer.
Kapur H; Warburton R; Pao JS; Dingee C; Chen L; McKevitt E
Am J Surg; 2021 Jun; 221(6):1172-1176. PubMed ID: 33795126
[TBL] [Abstract][Full Text] [Related]
13. An exploration of Australian psychologists' role in assessing women considering risk-reducing or contralateral prophylactic mastectomy.
Braude L; Laidsaar-Powell R; Gilchrist J; Kirsten L; Juraskova I
Breast; 2017 Apr; 32():105-111. PubMed ID: 28135658
[TBL] [Abstract][Full Text] [Related]
14. Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States.
Yao K; Bleicher R; Moran M; Chang C; Dietz J; Stearns V; Connolly J; Sarantou T; Kurtzman S;
Cancer Med; 2020 May; 9(9):3088-3096. PubMed ID: 32159280
[TBL] [Abstract][Full Text] [Related]
15. Contralateral prophylactic mastectomy: A qualitative approach to exploring the decision making process.
Greener JR; Bass SB; Lepore SJ
J Psychosoc Oncol; 2018; 36(2):145-158. PubMed ID: 29064771
[TBL] [Abstract][Full Text] [Related]
16. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
Pinell-White XA; Kolegraff K; Carlson GW
Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
[TBL] [Abstract][Full Text] [Related]
17. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
Agarwal S; Pappas L; Matsen CB; Agarwal JP
Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
[TBL] [Abstract][Full Text] [Related]
18. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
[TBL] [Abstract][Full Text] [Related]
19. Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.
Katz SJ; Hawley ST; Hamilton AS; Ward KC; Morrow M; Jagsi R; Hofer TP
JAMA Surg; 2018 Jan; 153(1):29-36. PubMed ID: 28903158
[TBL] [Abstract][Full Text] [Related]
20. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
